CSL successfully issues bonds in US debt markets
Filed with ASX · · 2 pages · English
Earlier from CSL
- Update on Acquisition of Vifor Pharma
- Statutory Accounts for Half Year Ended 31 December 2021
- CSL completes A$750 million Share Purchase Plan
- Successful Completion of A$6.3B Institutional Placement
- Investor Presentation CSL Swiss Tender Acquisition of Vifor
Later from CSL
- Vifor update ASX Announcement for lodgement
- Finalisation of Vifor Pharma Acquisition
- CSL Vifor Market Briefing
- CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
- Appointment of CSLs next CEO & Managing Director
Follow CSL into a list and get an email when it puts out news.
Follow CSL